# Kwality Pharmaceuticals Ltd (KPL)
> Exchange: NSE | Sector: Pharma | ISIN: 

## Price
Current Price: ₹2087
Day Change: +1.51%
52W High: ₹1770
52W Low: ₹1561
Market Cap: ₹1,784 Cr

## Valuation
P/E: 31.54
P/B: 6.15
EPS: ₹54.5
Book Value: ₹279.5
Dividend Yield: 0%

## Returns
1Y Return: 85.79%

## Profitability
ROE: 15.75%
ROCE: 0%
Debt/Equity: 0.38
Revenue Growth: 46.2%
Profit Growth: 87.9%
EBITDA Margin: 22.83%
Operating Margin: 20.79%

## About
Kwality Pharmaceuticals Ltd is a Drug Manufacturers - Specialty & Generic company listed on NSE. The page combines exchange quotes, financial statements, shareholding, filings, and news so investors can review the business in one place.
Sector: Pharma
Industry: Drug Manufacturers - Specialty & Generic
Sub Industry: Unknown

## Business Model
Overview: Kwality Pharmaceuticals Ltd makes money through Domestic formulations, Exports and regulated markets, Specialty or institutional sales in Drug Manufacturers - Specialty & Generic. Revenue quality depends on demand growth, margin discipline, balance-sheet strength, and the company's ability to defend its position within Pharma.
Source: Derived from stock data
Revenue Streams:
- Domestic formulations
- Exports and regulated markets
- Specialty or institutional sales
Operating Model:
- Develops, manufactures, distributes, or services healthcare products across regulated channels.
- Approvals, product mix, compliance quality, and R&D productivity shape growth.
Recent Context:
- Announcement: Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
- Quarterly Report: Board Meeting Intimation for Considering The Standalone & Consolidated Audited Financial Results For The Quarter And Year Ended March 31, 2026
- BSE Filing: Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

## Access
Current tier: anonymous
More history: Register free to see 9 more years.

## Data Freshness
Quote Updated: 2026-05-21T20:00:03.547Z
Price History Updated: 2026-05-18T22:58:58.952Z
Latest Price History Date: 2026-05-18
Technicals Updated: 2026-05-18T22:58:58.952Z
Quant Updated: 2026-05-18T22:58:58.952Z
Sentiment Updated: 2026-05-18T22:58:58.952Z
Financials Status: current
Financials Updated: 2026-05-18T09:30:01.601Z
Financials Last Attempt: 2026-05-18T09:30:01.601Z
Financials Provider Tried: database
Latest P&L Period: FY 2025
Latest Balance Sheet Period: FY 2025
Latest Cash Flow Period: FY 2025

## P&L (Mar 2015)
Revenue: ₹60 Cr
Operating Profit: ₹4 Cr (OPM 6%)
Net Profit: ₹1 Cr
Tax: ₹2 Cr

## Annual P&L History
Mar 2015: Rev ₹60Cr | PAT ₹1Cr | OPM 6%
Mar 2016: Rev ₹52Cr | PAT ₹1Cr | OPM 6%
Mar 2017: Rev ₹74Cr | PAT ₹1Cr | OPM 7%

## Balance Sheet (Mar 2015)
Total Assets: ₹35 Cr
Total Liabilities: ₹35 Cr
Borrowings: ₹6 Cr
Cash: ₹undefined Cr

## Shareholding
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%

## Board
- Ramesh  Arora, MD & Director
- Aditya  Arora, CFO & Whole Time Director
- Ajay Kumar Arora, Whole Time Director
- Anju  Arora, Whole Time Director
- Geeta  Arora, Whole Time Director

---
Source: rupiya.io/stocks/kpl
Disclaimer: For research and education only. Not investment advice.